Regulations.gov document
Reference 6 - Recommendations to Reduce the Possible Risk of Transmission of…
Supporting & Related Material · FDA-2024-D-1244 · posted Apr 30, 2024
Key facts
| Document ID | FDA-2024-D-1244-0008 |
|---|---|
| Title | Reference 6 - Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Guidance for Industry, May 2022, https://www.fda.gov/media/124156/download. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2024-D-1244 |
| Posted | Apr 30, 2024 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: